Genecentric Therapeutics, Inc.;The University Of North Carolina At Chapel Hill
发明人:
FARUKI, Hawazin,LAI-GOLDMAN, Myla,MAYHEW, Greg,SERODY, Jonathan,PEROU, Charles,HAYES, David Neil
申请号：
EP17800091
公开号：
EP3458612A4
申请日:
2017.05.17
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Methods and compositions are provided for determining a subtype of lung adenocarcinoma (AD) of an individual by detecting the expression level of at least one classifier biomarker selected from a group of gene signatures for lung adenocarcinoma. Also provided herein are methods and compositions for determining the response of an individual with an adenocarcinoma subtype to a therapy such as immunotherapy.
